Green Light for Post-Operative Wellness

ConditionSurgery

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorRebecca E Kotcher, MD

About this trial

This is an unblinded, parallel group randomized controlled trial to evaluate bright green light as an adjunct therapy after surgery at UPMC Shadyside. The primary outcome measure will be pain intensity with secondary outcome measures including opioid requirements, sleep quality, mood, and overall post-operative recovery. Specific aims/hypotheses for this study are as follows:

Aim 1: To assess bright green light therapy's potential as a complementary post-operative analgesic strategy in patients recovering from surgery Hypothesis 1: Participants exposed to bright green light, in comparison to dim white (ambient) light, will have improved postoperative pain scores and lower opioid use.

Aim 2: To examine the impact of bright green light therapy on patient-centered measures of post-operative recovery that may be related to improved circadian function.

Hypothesis 2: Participants exposed to bright green light, in comparison to dim white (ambient) light, will have improved quality of post-operative recovery, enhanced sleep, and reduced anxiety and depression.

Eligibility criteria

Qualifiers

Age >/= 18 years

Planned to undergo laparoscopic or robotic surgery at UPMC Shadyside Hospital

Anticipated post-operative length of stay >/= 48 hours

Able to speak and read English fluently, with the capacity to provide informed consent and complete the associated surveys independently

Disqualifiers

Pregnancy

History of significant ocular issues/dysfunction (†‡ ) (e.g., glaucoma, ocular trauma, macular degeneration, cataracts) that would interfere with the ocular mechanism of action

History of significant neurological disease (‡) (e.g., traumatic brain injury, stroke, neurodegenerative disease) that would compromise the reliability of pain screening and/or interfere with the central mechanism of action

History of bipolar disorder or schizophrenia, which could increase the risk of an adverse reaction to light exposure (i.e., acute mania)

Trial design

Treatments tested in this trial

Bright Green Light Therapy
Dim White Light Therapy

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Rebecca E Kotcher, MD

Lead sponsor

University of Pittsburgh

Sponsor institution

Source ClinicalTrials.gov